Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jesus Guzman Valle"'
Autor:
Fernando Martínez-Cortés, Allan Noé Domínguez-Romero, Eréndira G. Pérez-Hernández, Diana L. Orozco-Delgado, Sandra Avila, Josué Odales, Jesus Guzman Valle, Goar Gevorkian, Karen Manoutcharian
Publikováno v:
Molecular Immunology. 157:91-100
Autor:
Josué Odales, Rodolfo Servín-Blanco, Fernando Martínez-Cortés, Jesus Guzman Valle, Allan Noé Domínguez-Romero, Goar Gevorkian, Karen Manoutcharian
Publikováno v:
Vaccine. 40(33)
The identification of novel targets for cancer immunotherapy and the development of new vaccine immunogens are subjects of permanent interest. MUC1 is an overexpressed antigen found in most tumors, and its overexpression correlates with poor prognosi
Publikováno v:
Archivum Immunologiae et Therapiae Experimentalis
In this communication, we will analyze some important factors and immunological phenomena related to neoantigen cancer vaccines, with particular emphasis on recently published Phase I clinical trials. Several obstacles and issues are addressed that c
Autor:
Fernando Martínez-Cortés, Goar Gevorkian, Jesus Guzman Valle, Allan Noé Domínguez-Romero, Karen Manoutcharian, Maria Elena Munguia, Josué Odales, Rodolfo Servín-Blanco
Publikováno v:
Molecular immunology. 139
After decades of cancer vaccine efforts, there is an imperious necessity for novel ideas that may result in better tumor control in patients. We have proposed the use of a novel Variable Epitope Library (VEL) vaccine strategy, which incorporates an u
Publikováno v:
Cellular Immunology
Highlights • Antibody-based therapies induce CDR-specific T and B cell responses. • Idiotype-anti-idiotype network alters immune system memory compartment. • Antigenized antibodies are efficient vaccine immunogen.
Antibodies, T cell recept
Antibodies, T cell recept
Publikováno v:
Open Journal of Pharmacology and Pharmacotherapeutics. 5:007-008
The outbreak of yet another epidemic (now COVID-19 pandemic) caused by SARS-CoV-2, has reminded the scientific community and, more importantly, the world that in spite of all the financial and human resource investment in vaccine development against